PEPG logo

PepGen (PEPG) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

06 May 2022

Indexes:

Not included

Description:

PepGen is a biotechnology company focused on developing innovative therapies for genetic diseases. They specialize in peptide-based drug delivery systems, aiming to improve treatment effectiveness and patient outcomes. Their research targets conditions caused by genetic mutations, offering hope for better management and potential cures.

Events Calendar

Earnings

Next earnings date:

Mar 06, 2025

Recent quarterly earnings:

Nov 07, 2024

Recent annual earnings:

Mar 06, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

18 Nov '24 B of A Securities
Neutral
08 Nov '24 Wedbush
Outperform
08 Nov '24 HC Wainwright & Co.
Buy
01 Aug '24 HC Wainwright & Co.
Buy
31 July '24 Wedbush
Outperform
15 May '24 Wedbush
Outperform
15 May '24 HC Wainwright & Co.
Buy
07 Mar '24 Wedbush
Outperform
30 Jan '24 Wedbush
Outperform
07 Sept '23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
PEPG
accesswire.com29 December 2024

NEW YORK, NY / ACCESSWIRE / December 29, 2024 / Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ:PEPG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
PEPG
accesswire.com26 December 2024

NEW YORK, NY / ACCESSWIRE / December 26, 2024 / Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ:PEPG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
PEPG
accesswire.com24 December 2024

NEW YORK, NY / ACCESSWIRE / December 24, 2024 / Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ:PEPG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
PEPG
accesswire.com17 December 2024

NEW YORK, NY / ACCESSWIRE / December 17, 2024 / Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ:PEPG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

PepGen Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out
PepGen Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out
PepGen Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out
PEPG
accesswire.com03 October 2024

LOS ANGELES, CA / ACCESSWIRE / October 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or "the Company") (NASDAQ:PEPG) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Investors Are Invited To Join The Schall Law Firm In An Inquiry Into PepGen Inc For Securities Fraud
Investors Are Invited To Join The Schall Law Firm In An Inquiry Into PepGen Inc For Securities Fraud
Investors Are Invited To Join The Schall Law Firm In An Inquiry Into PepGen Inc For Securities Fraud
PEPG
accesswire.com28 September 2024

LOS ANGELES, CA / ACCESSWIRE / September 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or "the Company") (NASDAQ:PEPG) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

PepGen Inc. Is Being Investigated For Violating Securities Laws And The Schall Law Firm Encourages Affected Shareholders To Lend A Hand
PepGen Inc. Is Being Investigated For Violating Securities Laws And The Schall Law Firm Encourages Affected Shareholders To Lend A Hand
PepGen Inc. Is Being Investigated For Violating Securities Laws And The Schall Law Firm Encourages Affected Shareholders To Lend A Hand
PEPG
accesswire.com27 September 2024

LOS ANGELES, CA / ACCESSWIRE / September 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or "the Company") (NASDAQ:PEPG) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

PepGen Inc Is Being Looked Into For Securities Related Infractions And Affected Investors Are Invited To Contact The Schall Law Firm
PepGen Inc Is Being Looked Into For Securities Related Infractions And Affected Investors Are Invited To Contact The Schall Law Firm
PepGen Inc Is Being Looked Into For Securities Related Infractions And Affected Investors Are Invited To Contact The Schall Law Firm
PEPG
accesswire.com22 September 2024

LOS ANGELES, CA / ACCESSWIRE / September 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or "the Company") (NASDAQ:PEPG) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Wants Shareholders To Join An Inquiry Into PepGen Inc. For Violating Securities Laws
The Schall Law Firm Wants Shareholders To Join An Inquiry Into PepGen Inc. For Violating Securities Laws
The Schall Law Firm Wants Shareholders To Join An Inquiry Into PepGen Inc. For Violating Securities Laws
PEPG
accesswire.com21 September 2024

LOS ANGELES, CA / ACCESSWIRE / September 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or "the Company") (NASDAQ:PEPG) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

PepGen Inc Is Being Investigated By The Schall Law Firm For Securities Fraud And Impacted Investors Are Urged To Reach Out
PepGen Inc Is Being Investigated By The Schall Law Firm For Securities Fraud And Impacted Investors Are Urged To Reach Out
PepGen Inc Is Being Investigated By The Schall Law Firm For Securities Fraud And Impacted Investors Are Urged To Reach Out
PEPG
accesswire.com20 September 2024

LOS ANGELES, CA / ACCESSWIRE / September 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or "the Company") (NASDAQ:PEPG) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

FAQ

  • What is the primary business of PepGen?
  • What is the ticker symbol for PepGen?
  • Does PepGen pay dividends?
  • What sector is PepGen in?
  • What industry is PepGen in?
  • What country is PepGen based in?
  • When did PepGen go public?
  • Is PepGen in the S&P 500?
  • Is PepGen in the NASDAQ 100?
  • Is PepGen in the Dow Jones?
  • When was PepGen's last earnings report?
  • When does PepGen report earnings?
  • Should I buy PepGen stock now?

What is the primary business of PepGen?

PepGen is a biotechnology company focused on developing innovative therapies for genetic diseases. They specialize in peptide-based drug delivery systems, aiming to improve treatment effectiveness and patient outcomes. Their research targets conditions caused by genetic mutations, offering hope for better management and potential cures.

What is the ticker symbol for PepGen?

The ticker symbol for PepGen is NASDAQ:PEPG

Does PepGen pay dividends?

No, PepGen does not pay dividends

What sector is PepGen in?

PepGen is in the Healthcare sector

What industry is PepGen in?

PepGen is in the Biotechnology industry

What country is PepGen based in?

PepGen is headquartered in United States

When did PepGen go public?

PepGen's initial public offering (IPO) was on 06 May 2022

Is PepGen in the S&P 500?

No, PepGen is not included in the S&P 500 index

Is PepGen in the NASDAQ 100?

No, PepGen is not included in the NASDAQ 100 index

Is PepGen in the Dow Jones?

No, PepGen is not included in the Dow Jones index

When was PepGen's last earnings report?

PepGen's most recent earnings report was on 7 November 2024

When does PepGen report earnings?

The next expected earnings date for PepGen is 6 March 2025

Should I buy PepGen stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions